Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole-exome sequencing of colorectal cancer cell lines MC38 and CT26

PROVIDER: PRJNA1172697 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30985665_1.fastq.gz	Fastqsanger.gz
	SRR30985665_2.fastq.gz	Fastqsanger.gz
	SRR30985666_1.fastq.gz	Fastqsanger.gz
	SRR30985666_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

E-PROT-110

Project description:Secretome analysis of colorectal cancer cell linesSW620, KM12SM, and KM12L4 cell lines

2023-11-08 | E-PROT-110 | ExpressionAtlas

E-GEOD-58966

Project description:Transcription profiling by high throughput sequencing in castration resistant prostate cancer cell lines

2025-01-24 | E-GEOD-58966 | ExpressionAtlas

E-PROT-18

Project description:Colorectal cancer cell line proteomes

2021-05-25 | E-PROT-18 | ExpressionAtlas

Whole-exome sequencing (WES) of single glands from opposite side of two colorectal tumors and WES of colorectal cancer xenografts derived from single cell culture to study tumor growth dynamics

Project description:Single Gland Whole-exome sequencing: building on our prior description of multi-region WES of colorectal tumors and targeted single gland sequencing (E-MTAB-2247), we performed WES of multiple single glands from different sides (right: A and left: B) of two tumors in this study (tumor O and U) on the illumina platform using the Agilent SureSelect 2.0 or illumina Nextera Rapid Capture Exome kit (SureSelect or NRCE, as indicated in the naming of fastq files). Colorectal Cancer Xenograft Whole-exome sequencing: The HCT116 and LoVo Mismatch-Repair-deficient colorectal adenocarcinoma cell lines were obtained from the ATCC and cultured under standard conditions. For both cell lines, a single âfoundingâ cell was cloned and expanded in vitro to ~6M cells. Two aliquots of ~1M cells were subcutaneously injected into opposite flanks (right and left) of a nude mouse and tumors allowed to reach a size of ~1B cells (1cm3) before the animal was sacrificed. Tumor tissue was collected separately from the right and left lesions and DNA was extracted for WES using the illumina TruSeq Exome kit or Nextera Rapid Capture Exome expanded Kits (Truseq or NRCEe), as was DNA from the first passage population (a polyclonal tissue culture for HCT116 and a polyclonal xenograft sample for LoVo), which were employed as a control to study mutation accumulation in culture and post xenotransplantation.

2017-05-01 | E-MTAB-5547 | biostudies-arrayexpress

Differentially expressed miRNAs in TGF-β1-knock down mice CT26 colorectal cancer cell lines vs controls

Project description:To investigate the role of TGF-β1-regulated miRNAs in the progression of colorectal cancer,we performed comprehensive miRMA microarray analysis on RNA derived from CT26 cell lines and TGF-β1 knock-down CT26 cell lines. We identified a novel set of TGF-β1-related miRNAs.

2013-12-16 | GSE53337 | GEO

Next generation sequencing of a unique set of glycovariant MC38 mouse colorectal cancer cell lines generated with CRISPR-Cas9 and CRISPR-dCas-VPR technology

Project description:To investigate the effect of different tumor-associated glycans, mouse colorectal cancer cells (MC38 cell line) were genetically modified using CRISPR-Cas9 and CRISPR-dCas-VPR technology targeting different genes involved in glycosylation pathways. To study the effect of altered glycosylation at the transcriptional level, next generation sequencing was performed on the entire panel of glycovariant MC38 cell lines. The MC38 knockout cell lines created with the CRISPR-Cas9 technology are: MC38-MOCK#1, MC38-CMAS KO, MC38-COSMC KO, MC38-CMAS+COSMC KO. The MC38 overexpressing cell lines generated with the CRISPR-dCas9-VPR technology are: MC38-MOCK#2, MC38-FUT4, MC38-FUT9. Details on the cell lines can be found in the corresponding manuscript(s).

2020-08-05 | GSE143700 | GEO

E-GEOD-53470

Project description:Transcription profiling by high throughput sequencing of c-JUN and JUND knockdown prostate cancer PC3 cell lines

2025-01-24 | E-GEOD-53470 | ExpressionAtlas

E-MTAB-2601

Project description:Breast cancer cell lines - palmitate vs control

2025-01-23 | E-MTAB-2601 | ExpressionAtlas

E-MTAB-2770

Project description:RNA-seq of 1019 human cancer cell lines from the Cancer Cell Line Encyclopedia

2025-01-23 | E-MTAB-2770 | ExpressionAtlas

E-PROT-28

Project description:Integrative proteomic profiling of ovarian cancer cell lines